A synthetic mixture of intestinal bacteria could one day replace stool transplants as a treatment for Clostridium difficile (C. difficile). C . difficile is a toxin-producing bacteria that can ...

Empirical intravenous vancomycin, piperacillin–tazobactam, and metronidazole were administered owing to concern about polymicrobial sepsis. Over the next hour, the patient became increasingly ...

A newly developed synthetic "poop" can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium, a new study suggests. A synthetic "poop" developed at the ...

Please provide your email address to receive an email when new articles are posted on . The nonprofit public stool bank, OpenBiome, has announced a new pilot program called PersonalBiome, which will ...

Most of us have heard of heart, liver and kidney transplants. But not many know about poop transplant or Faecal microbiota transplantation (FMT). FMT, also known as stool transplant, is approved ...

Clostridium difficile infection (CDI) represents a public health problem worldwide as it is associated with significant morbidity and mortality 1,2,3,4. This infection, due to the establishment of ...

Working in the hospital again always provides valuable perspective. I love (most of) the patient care, and seeing differences in patterns over time, as I only see patients episodically. One of the ...

A 70-year-old woman with a history of Clostridium difficile infection returned to the clinic with abdominal pain and diarrhea. Three stool samples were negative for C. difficile and WBCs. Would you ...

Louie et al. [45] conducted a randomized, open-label study of the safety and efficacy of fidaxomicin in patients with mild-to-moderately severe CDI. Adults with three or more diarrheal stools (defined ...

What are the characteristics of C. difficile infection? Clostridium difficile is a Gram-positive bacterium that induces inflammation in the intestine via two toxins, namely TcdA and TcdB. A variety of ...

Infection with the pathogen Clostridium difficile is a significant source of healthcare-associated infections and estimated to account for 12 percent of all HAIs in the U.S.1 C. diff infection is the ...